Amrita Krishnan, M.D., director of City of Hope’s Multiple Myeloma Program, says the City of Hope is at the forefront of transforming the way myeloma is treated and that, as a result, more myeloma patients are able to live active, productive lives.
Amrita Krishnan, M.D., was instrumental in bringing successful transplant therapy to HIV patients with lymphoma when many believed such patients were too weak to tolerate the procedure. “We have patients who had been told to get their affairs in order,” she says. “Years later, they are still here.” Dr. Krishnan now directs the Judy and Bernard Briskin Center for Multiple Myeloma Research at City of Hope, seeking to make gains in one of the most rapidly changing areas in cancer research. A key member of the City of Hope team since 1996, Dr. Krishnan trained at Albany Medical College and served as a clinical fellow at Harvard Medical School.